Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration

Shih‐Chang Hsueh(Taipei Medical University), Nigel H. Greig(National Institutes of Health)
Journal of Biomedical Science
June 16, 2025
Cited by 5


Related Papers